Loading…
Company to issue 2,250,000 shares at $2.00 per share
Bluejay Diagnostics, Inc. (Nasdaq: BJDX) announced on October 9, 2025, a $4.5 million private placement. The company will issue 2,250,000 shares at a price of $2.00 per share. Additionally, Bluejay Diagnostics expanded its partnership with SanyoSeiko to support the commercialization of its Symphony platform.
The private placement includes the issuance of 2,250,000 shares at $2.00 per share, raising a total of $4.5 million. The company also holds warrants to purchase 4,500,000 shares at an exercise price of $1.75 per share.
As of the latest data, Bluejay Diagnostics has a free float of 1,270,000 shares and 1,814,100 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.